vimarsana.com
Home
Live Updates
Leader in Breast Cancer First-in-Class Drug Development, Mar
Leader in Breast Cancer First-in-Class Drug Development, Mar
Leader in Breast Cancer First-in-Class Drug Development, Martin S. Olivo, MD, MSc, joins Phoenix Molecular Designs Advisory Board
/PRNewswire/ - Phoenix Molecular Designs (PhoenixMD), a clinical-stage biopharmaceutical company dedicated to developing precise cancer therapeutics, today...
Related Keywords
China ,
Phoenix ,
Arizona ,
United States ,
Canada ,
Buenos Aires ,
Distrito Federal ,
Argentina ,
El Salvador ,
Vancouver ,
British Columbia ,
Salvador ,
Sandi Dunn ,
Martins Olivo ,
School Of Medicine ,
Clinical Development At Immunomedics Inc ,
International Program Team Leader For Halaven ,
Eisai Inc ,
Immunomedics Inc ,
Austral University ,
Protara Therapeutics Inc ,
Pharmacological Research ,
Clinical Development At Gilead Sciences Inc ,
Molecular Designs ,
Chief Medical Officer ,
Vice President ,
Breast Cancer Clinical Development Lead ,
Gilead Sciences ,
Vice President Clinical Development ,
Phoenix Molecular ,
Protara Therapeutics ,
Clinical Development ,
Global Clinical Lead ,
Daiichi Sankyo Cancer Enterprise ,
International Program Team Leader ,
Clinical Oncologist ,
Enrique Torn ,
National Cancer Institute ,
Canada Clinical Trials ,
Phoenix Molecular Designs ,